MYC and T-cell non-Hodgkin lymphoma: This activity has been demonstrated especially in natural killer/T-cell lymphoma, in which cyclin D transcription is activated by EZH2 upregulation via Myc-mediated mRNA inhibition promoting cell proliferation without a methyltransferase activity (65).